Human PAK1 /alpha-PAK/IDDMSSD ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_001128620.1)
Cat. No.: pGMPC000262
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human PAK1 /alpha-PAK/IDDMSSD Non-Viral expression plasmid (overexpression vector) for mouse PAK1 overexpression in unique cell transient transfection and stable cell line development.
Go to
PAK1/PAK1 /alpha-PAK products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMPC000262 |
| Gene Name | PAK1 |
| Accession Number | NM_001128620.1 |
| Gene ID | 5058 |
| Species | Human |
| Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
| Insert Length | 1662 bp |
| Gene Alias | alpha-PAK,IDDMSSD,p65-PAK,PAKalpha |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGTCAAATAACGGCCTAGACATTCAAGACAAACCCCCAGCCCCTCCGATGAGAAATACCAGCACTATGATTGGAGCCGGCAGCAAAGATGCTGGAACCCTAAACCATGGTTCTAAACCTCTGCCTCCAAACCCAGAGGAGAAGAAAAAGAAGGACCGATTTTACCGATCCATTTTACCTGGAGATAAAACAAATAAAAAGAAAGAGAAAGAGCGGCCAGAGATTTCTCTCCCTTCAGATTTTGAACACACAATTCATGTCGGTTTTGATGCTGTCACAGGGGAGTTTACGGGAATGCCAGAGCAGTGGGCCCGCTTGCTTCAGACATCAAATATCACTAAGTCGGAGCAGAAGAAAAACCCGCAGGCTGTTCTGGATGTGTTGGAGTTTTACAACTCGAAGAAGACATCCAACAGCCAGAAATACATGAGCTTTACAGATAAGTCAGCTGAGGATTACAATTCTTCTAATGCCTTGAATGTGAAGGCTGTGTCTGAGACTCCTGCAGTGCCACCAGTTTCAGAAGATGAGGATGATGATGATGATGATGCTACCCCACCACCAGTGATTGCTCCACGCCCAGAGCACACAAAATCTGTATACACACGGTCTGTGATTGAACCACTTCCTGTCACTCCAACTCGGGACGTGGCTACATCTCCCATTTCACCTACTGAAAATAACACCACTCCACCAGATGCTTTGACCCGGAATACTGAGAAGCAGAAGAAGAAGCCTAAAATGTCTGATGAGGAGATCTTGGAGAAATTACGAAGCATAGTGAGTGTGGGCGATCCTAAGAAGAAATATACACGGTTTGAGAAGATTGGACAAGGTGCTTCAGGCACCGTGTACACAGCAATGGATGTGGCCACAGGACAGGAGGTGGCCATTAAGCAGATGAATCTTCAGCAGCAGCCCAAGAAAGAGCTGATTATTAATGAGATCCTGGTCATGAGGGAAAACAAGAACCCAAACATTGTGAATTACTTGGACAGTTACCTCGTGGGAGATGAGCTGTGGGTTGTTATGGAATACTTGGCTGGAGGCTCCTTGACAGATGTGGTGACAGAAACTTGCATGGATGAAGGCCAAATTGCAGCTGTGTGCCGTGAGTGTCTGCAGGCTCTGGAGTTCTTGCATTCGAACCAGGTCATTCACAGAGACATCAAGAGTGACAATATTCTGTTGGGAATGGATGGCTCTGTCAAGCTAACTGACTTTGGATTCTGTGCACAGATAACCCCAGAGCAGAGCAAACGGAGCACCATGGTAGGAACCCCATACTGGATGGCACCAGAGGTTGTGACACGAAAGGCCTATGGGCCCAAGGTTGACATCTGGTCCCTGGGCATCATGGCCATCGAAATGATTGAAGGGGAGCCTCCATACCTCAATGAAAACCCTCTGAGAGCCTTGTACCTCATTGCCACCAATGGGACCCCAGAACTTCAGAACCCAGAGAAGCTGTCAGCTATCTTCCGGGACTTTCTGAACCGCTGTCTCGAGATGGATGTGGAGAAGAGAGGTTCAGCTAAAGAGCTGCTACAGGTGAGAAAACTGAGGTTTCAAGTGTTTAGTAACTTTTCCATGATAGCTGCATCAATTCCTGAAGATTGCCAAGCCCCTCTCCAGCCTCACTCCACTGATTGCTGCAGCTAA |
| ORF Protein Sequence | MSNNGLDIQDKPPAPPMRNTSTMIGAGSKDAGTLNHGSKPLPPNPEEKKKKDRFYRSILPGDKTNKKKEKERPEISLPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKSEQKKNPQAVLDVLEFYNSKKTSNSQKYMSFTDKSAEDYNSSNALNVKAVSETPAVPPVSEDEDDDDDDATPPPVIAPRPEHTKSVYTRSVIEPLPVTPTRDVATSPISPTENNTTPPDALTRNTEKQKKKPKMSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQVRKLRFQVFSNFSMIAASIPEDCQAPLQPHSTDCCS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T37961-Ab | Anti-PAK1/ PAKalpha monoclonal antibody |
| Target Antigen | GM-Tg-g-T37961-Ag | PAK1 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP005538 | Human PAK1 Lentivirus plasmid |
| ORF Viral Vector | pGMLP-SPh-062 | Human PAK1 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-SPh-202 | Human PAK1 Adenovirus plasmid |
| ORF Viral Vector | pGMPC000262 | Human PAK1 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | pGMPC000263 | Human pak1 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP005538 | Human PAK1 Lentivirus particle |
| ORF Viral Vector | vGMLP-SPh-062 | Human PAK1 Lentivirus particle |
| ORF Viral Vector | vGMAP-SPh-202 | Human PAK1 Adenovirus particle |
Target information
| Target ID | GM-T37961 |
| Target Name | PAK1 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
5058 |
| Gene ID |
100063217 (Equus caballus), 101087171 (Felis catus), 18479 (Mus musculus), 29431 (Rattus norvegicus) 5058 (Homo sapiens), 533729 (Bos taurus), 607885 (Canis lupus familiaris), 698585 (Macaca mulatta) |
| Gene Symbols & Synonyms | PAK1,Pak1,Paka,PAK-1,IDDMSSD,p65-PAK,PAKalpha,alpha-PAK |
| Target Alternative Names | Alpha-PAK,IDDMSSD,PAK-1,PAK1,PAKalpha,Pak1,Paka,Serine/threonine-protein kinase PAK 1,alpha-PAK,p21-activated kinase 1 (PAK-1),p65-PAK |
| Uniprot Accession |
O88643,P35465,Q08E52,Q13153
Additional SwissProt Accessions: O88643,P35465,Q13153,Q08E52 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, Axon guidance, Focal adhesion, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Epithelial cell signaling in Helicobacter pylori infection, Pathogenic Escherichia coli infection, Proteoglycans in cancer, Renal cell carcinoma |
| Gene Ensembl | ENSECAG00000017840, ENSMUSG00000030774, ENSG00000149269, ENSBTAG00000010191, ENSCAFG00845009162, ENSMMUG00000001387 |
| Target Classification | Kinase, Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


